Article
Paraoxonase 1 Met--Leu 54 polymorphism is associated with Parkinson's disease.
Journal of the neurological sciences - 1 Mar 2001
Akhmedova S N, Yakimovsky A K, Schwartz E I
Abstract excerpt
Two up-to-date known paraoxonase 1 (PON1) polymorphisms (Gln--Arg 191 and Leu--Met 54) affect the hydrolysis of toxic oxons and might intensify effects of pollutants, organophosphates and other environmental chemicals in development of Parkinson's disease (PD). We reported previously that PON1 G1n--Arg 191 polymorphism did not influence on the susceptibility to PD. In the present study we have investigated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
